Terrence Kearney
Director/Board Member chez VERTEX PHARMACEUTICALS INCORPORATED
Fortune : 3 M $ au 31/03/2024
Postes actifs de Terrence Kearney
Sociétés | Poste | Début | Fin |
---|---|---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Director/Board Member | 17/05/2011 | - |
Independent Dir/Board Member | 17/05/2011 | - |
Historique de carrière de Terrence Kearney
Anciens postes connus de Terrence Kearney
Sociétés | Poste | Début | Fin |
---|---|---|---|
Levo Therapeutics, Inc.
Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Director/Board Member | 01/01/2018 | 01/06/2022 |
ACCELERON PHARMA INC. | Director/Board Member | 14/07/2014 | 19/11/2021 |
Independent Dir/Board Member | 14/07/2014 | 19/11/2021 | |
AVEXIS INC | Director/Board Member | 01/01/2016 | 14/05/2018 |
Independent Dir/Board Member | 01/01/2016 | 14/05/2018 | |
INNOVIVA, INC. | Director/Board Member | 30/10/2014 | 26/04/2016 |
Independent Dir/Board Member | 30/10/2014 | 26/04/2016 | |
HOSPIRA, INC. | Chief Operating Officer | 01/04/2004 | 31/12/2010 |
Director of Finance/CFO | 01/04/2004 | 01/01/2006 | |
ABBOTT LABORATORIES | Corporate Officer/Principal | 01/01/1996 | 01/04/2001 |
Treasurer | 01/01/2001 | 01/04/2004 |
Formation de Terrence Kearney
University of Illinois | Undergraduate Degree |
University of Denver | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 10 |
Opérationnelle
Director/Board Member | 5 |
Independent Dir/Board Member | 4 |
Chief Operating Officer | 1 |
Sectorielle
Health Technology | 8 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
ABBOTT LABORATORIES | Health Technology |
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
INNOVIVA, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Hospira, Inc.
Hospira, Inc. Pharmaceuticals: MajorHealth Technology Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL. | Health Technology |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Novartis Gene Therapies, Inc.
Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
Levo Therapeutics, Inc.
Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Health Technology |
- Bourse
- Insiders
- Terrence Kearney
- Expérience